Cagrilintide is a long-performing amylin receptor agonist created by Novo Nordisk for bodyweight administration and metabolic health and fitness. It mimics the action of naturally developing amylin hormone, that's co-secreted with insulin from pancreatic beta cells.By activating these receptors, cagrilintide Also slows the rate of gastric emptying